Skyrizi Launch Skyrockets, Boosting AbbVie Hopes For Humira Successors

 
• By Joseph Haas
  
Pebble tower on the seaside - Image
AbbVie is successfully balancing Humira's biosimilar erosion with new brand growth
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business